Search Results - Pier Luigi Zinzani

Refine Results
  1. 1
    Lymphoma immunotherapy

    Lymphoma immunotherapy by Pier Luigi Zinzani

    Published 2018-06-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Il prezzo dei farmaci orfani in Italia: il caso di Citarabina Depot (DepoCyte®) nella meningite linfomatosa

    Il prezzo dei farmaci orfani in Italia: il caso di Citarabina Depot (DepoCyte®) nella meningite linfomatosa by Orietta Zaniolo, Mario Eandi, Pier Luigi Zinzani

    Published 2004-09-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Current and future therapies for follicular lymphoma

    Current and future therapies for follicular lymphoma by Pier Luigi Zinzani, Javier Muñoz, Judith Trotman

    Published 2024-08-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Prolonged disease-free survival in elderly relapsed diffuse large B-cell lymphoma patients treated with lenalidomide plus rituximab

    Prolonged disease-free survival in elderly relapsed diffuse large B-cell lymphoma patients treated with lenalidomide plus rituximab by Pier Luigi Zinzani, Cinzia Pellegrini, Lisa Argnani, Alessandro Broccoli

    Published 2016-09-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    New Treatment Options in Advanced Stage Follicular Lymphoma

    New Treatment Options in Advanced Stage Follicular Lymphoma by Kai Hübel, Gilles Salles, Robert Marcus, Pier Luigi Zinzani, Martin Dreyling

    Published 2018-12-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Management of central nervous system relapse in a young patient affected by primary mediastinal large B‐cell lymphoma: A case report

    Management of central nervous system relapse in a young patient affected by primary mediastinal large B‐cell lymphoma: A case report by Miriam Marangon, Beatrice Casadei, Alessandro Broccoli, Lisa Argnani, Michele Cavo, Pier Luigi Zinzani

    Published 2020-06-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Expression of CD52 in peripheral T-cell lymphoma

    Expression of CD52 in peripheral T-cell lymphoma by Pier Paolo Piccaluga, Claudio Agostinelli, Simona Righi, Pier Luigi Zinzani, Stefano A. Pileri

    Published 2007-04-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Impressive continuous complete response after mogamulizumab in a heavily pre-treated Sézary syndrome patient

    Impressive continuous complete response after mogamulizumab in a heavily pre-treated Sézary syndrome patient by Pier Luigi Zinzani, Ginevra Lolli, Beatrice Casadei, Lisa Argnani, Laura Nanni, Michele Cavo

    Published 2020-06-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    A patient with plasmablastic lymphoma achieving long-term complete remission after thalidomide-dexamethasone induction and double autologous stem cell transplantation: a case report

    A patient with plasmablastic lymphoma achieving long-term complete remission after thalidomide-dexamethasone induction and double autologous stem cell transplantation: a case repor... by Alessandro Broccoli, Laura Nanni, Vittorio Stefoni, Claudio Agostinelli, Lisa Argnani, Michele Cavo, Pier Luigi Zinzani

    Published 2018-06-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Immune-related adverse events in the treatment of non-Hodgkin lymphoma with immune checkpoint inhibitors

    Immune-related adverse events in the treatment of non-Hodgkin lymphoma with immune checkpoint inhibitors by Lisa Argnani, Beatrice Casadei, Carla Pelusi, Valentina Lo Preiato, Uberto Pagotto, Francesco Bertoni, Pier Luigi Zinzani

    Published 2022-02-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Brain dysfunction in COVID‐19 and CAR‐T therapy: cytokine storm‐associated encephalopathy

    Brain dysfunction in COVID‐19 and CAR‐T therapy: cytokine storm‐associated encephalopathy by Umberto Pensato, Lorenzo Muccioli, Ilaria Cani, Damir Janigro, Pier Luigi Zinzani, Maria Guarino, Pietro Cortelli, Francesca Bisulli

    Published 2021-04-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients

    Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients by Gianmarco Bagnato, Vittorio Stefoni, Alessandro Broccoli, Lisa Argnani, Cinzia Pellegrini, Beatrice Casadei, Francesca Bonifazi, Pier Luigi Zinzani

    Published 2024-01-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    CD30 expression in peripheral T-cell lymphomas

    CD30 expression in peripheral T-cell lymphomas by Elena Sabattini, Marco Pizzi, Valentina Tabanelli, Pamela Baldin, Carlo Sagramoso Sacchetti, Claudio Agostinelli, Pier Luigi Zinzani, Stefano A. Pileri

    Published 2013-08-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Controversies in the Treatment of Peripheral T-cell Lymphoma

    Controversies in the Treatment of Peripheral T-cell Lymphoma by Emmanuel Bachy, Alessandro Broccoli, Claire Dearden, Laurence de Leval, Philippe Gaulard, Raphael Koch, Franck Morschhauser, Lorenz Trümper, Pier Luigi Zinzani

    Published 2020-10-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study

    Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study by Maria Caterina Cavallo, Marianna Cavazza, Francesca Bonifazi, Beatrice Casadei, Ilaria Cutini, Barbara Tonietti, Riccardo Saccardi, PierLuigi Zinzani, Claudio Jommi

    Published 2024-01-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    P1067: ESTIMATING THE RELATIVE EFFICACY OF FAVEZELIMAB WHEN USED IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH PD-1–REFRACTORY CLASSICAL HODGKIN LYMPHOMA

    P1067: ESTIMATING THE RELATIVE EFFICACY OF FAVEZELIMAB WHEN USED IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH PD-1–REFRACTORY CLASSICAL HODGKIN LYMPHOMA by Philippe Armand, Pier Luigi Zinzani, John Timmerman, Nathalie Johnson, David Lavie, Kannan Thiagarajan, Brian Topp, Pallavi Pillai, Alex F. Herrera

    Published 2023-08-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective

    Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective by Anna Sureda, Marc André, Peter Borchmann, Maria G. da Silva, Christian Gisselbrecht, Theodoros P. Vassilakopoulos, Pier Luigi Zinzani, Jan Walewski

    Published 2020-11-01
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    The treatment of primary mediastinal large B-cell lymphoma: a two decades monocentric experience with 98 patients

    The treatment of primary mediastinal large B-cell lymphoma: a two decades monocentric experience with 98 patients by Alessandro Broccoli, Beatrice Casadei, Vittorio Stefoni, Cinzia Pellegrini, Federica Quirini, Lorenzo Tonialini, Alice Morigi, Miriam Marangon, Lisa Argnani, Pier Luigi Zinzani

    Published 2017-04-01
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    Brentuximab vedotin in the treatment of elderly Hodgkin lymphoma patients at first relapse or with primary refractory disease: a phase II study of FIL ONLUS

    Brentuximab vedotin in the treatment of elderly Hodgkin lymphoma patients at first relapse or with primary refractory disease: a phase II study of FIL ONLUS by Vittorio Stefoni, Miriam Marangon, Alessandro Re, Arben Lleshi, Maurizio Bonfichi, Antonello Pinto, Nicola Bianchetti, Cinzia Pellegrini, Lisa Argnani, Pier Luigi Zinzani

    Published 2020-02-01
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    Copanlisib population pharmacokinetics from phase I–III studies and exposure–response relationships in combination with rituximab

    Copanlisib population pharmacokinetics from phase I–III studies and exposure–response relationships in combination with rituximab by Peter N. Morcos, Jonathan Moss, Rupert Austin, Florian Hiemeyer, Pier Luigi Zinzani, Vita Beckert, Lidia Mongay Soler, Barrett H. Childs, Dirk Garmann

    Published 2023-11-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: